Antioxidative Effects of Rosuvastatin in Low-to-Moderate Cardiovascular Risk Subjects
, , , , , , e
22 apr 2022
INFORMAZIONI SU QUESTO ARTICOLO
Pubblicato online: 22 apr 2022
Pagine: 65 - 75
DOI: https://doi.org/10.2478/prilozi-2022-0007
Parole chiave
© 2022 Ana Vavlukis et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Vavlukis, Ana
Ss. Cyril and Methodius University in Skopje, Faculty of Pharmacy
Cardiovascular ICCC-Program, Research Institute Hospital de la Santa Creu i Sant PauBarcelona, Spain
Vavlukis, Marija
Ss. Cyril and Methodius University in Skopje, Faculty of Medicine
Mladenovska, Kristina
Ss. Cyril and Methodius University in Skopje, Faculty of Pharmacy
Dimovski, Aleksandar
Ss. Cyril and Methodius University in Skopje, Faculty of Pharmacy
Muñoz-García, Natàlia
Cardiovascular ICCC-Program, Research Institute Hospital de la Santa Creu i Sant PauBarcelona, Spain
de Santisteban Villaplana, Victoria
Cardiovascular ICCC-Program, Research Institute Hospital de la Santa Creu i Sant PauBarcelona, Spain
Padro, Teresa
Cardiovascular ICCC-Program, Research Institute Hospital de la Santa Creu i Sant PauBarcelona, Spain
Badimon, Lina
Cardiovascular ICCC-Program, Research Institute Hospital de la Santa Creu i Sant PauBarcelona, Spain